The Pharmacoepidemiology and Pharmacodynamics (P&P) Research Group is a multidisciplinary group that includes medical doctors from different specialties, pharmacists from different specialties, and graduates in nursing. The research areas include topics in basic, clinical and epidemiological Pharmacology. The group aims to evaluate the efficacy, safety and efficiency of medical technology linked to the use of drugs, either as prevention or treatment of diseases. It also focuses on the analysis of drug use patterns as a starting point to achieve their rational application.
Its objectives are focused on the following basic areas:
- Medical oncology
- Infectious diseases
- Inflammatory diseases
- Drug Repurposing
- Artificial nutrition
- The safety and effectiveness of medications
The fundamental tool of pharmacoepidemiology is the clinical trial. For this reason, the group's is actively participating in multicenter national or international clinical trials for the development of new drugs in the different areas of interest.
The Pharmacodynamic part of the group is focused on deciphering the mechanism of action of new drugs and the identification of new, previously unnoticed, applications of the approved drugs.
- Project: Drug repurposing to tackle Crohn's disease progression: Screening of a FDA-approved drug library against TNF-α-driven cell death in autophagy-deficient genetic models
- Code: PID2020-114034RB-I00
- Year: 2021
- Amount:110.352 Euros
- Funder: Ministerio de Ciencia e Innovación
Rodriguez, AT; Viejo, MN; Maradey, P; Canal-Sotelo, J; Mancilla, PG; Rivero, SG; Casillas, IR; Abian, MH; Bermudo, CL
Impact of individualized management of breakthrough cancer pain on quality of life in advanced cancer patients: CAVIDIOPAL study
SUPPORTIVE CARE IN CANCER 29 4799-4807. .